Vaginal laser rejuvenation may or may not provide relief from menopause vaginal dryness, irritation, itching, burning, painful intercourse and urinary symptoms.
Depending on the Source the definitions of genitourinary syndrome of menopause (GSM) or vulovaginal atrophy (VVA) may vary. In Vulvovaginal Symptoms After Menopause the Australasian Menopause Society’s definitions are:
- “As women age they will experience changes to their vagina and urinary system largely due to decreasing levels of the hormone oestrogen
- Changes, which may cause dryness, irritation, itching and pain with intercourse are known as the genito-urinary syndrome of menopause (GSM) and can affect up to 50% of postmenopausal women. GSM was previously known as atrophic vaginitis or vulvovaginal atrophy (VVA)”.
In Getting Relief From Sexual Dysfunction and Incontinence Caused By Menopause the North American Menopause Society (NAMS) dated 08 October 2018, elaborate on:
In FDA Warns Against Use of Energy-Based Devices To Perform Vaginal ‘Rejuvenation’ or Vaginal Cosmetic Procedures: FDA Safety Communication [Date Issued: 30 July 2018 and Updated: 20 November 2018], the (United States) Food and Drug and Administration (FDA) elaborate on:
- “Be aware that the safety and effectiveness of energy-based devices to perform vaginal “rejuvenation” or cosmetic vaginal procedures has not been established
- Understand that the FDA has not cleared or approved any energy-based medical device for vaginal “rejuvenation” or vaginal cosmetic procedures, or for the treatment of vaginal symptoms related to menopause, urinary incontinence, or sexual function
- Discuss the benefits and risks of all available treatment options for vaginal symptoms with your health care provider
- If you have undergone treatment for vaginal “rejuvenation” and experienced a complication, you are encouraged to file a report through MedWatch, the FDA Safety Information and Adverse Event Reporting program”.
In the Statement From FDA Commissioner Scott Gottlieb, M.D. and Jeff Shuren, M.D., Director of the Center for Devices and Radiological Health, on FDA’s Updates To Medical Device Safety Action Plan To Enhance Post-Market Safety: Focusing on Women’s Health – – “Vaginal Rejuvenation” Devices dated 20 November 2018, the FDA elaborate on:
- Non Hormone Remedies
- Vaginal Lubricants…
- Vaginal Moisturizers…
- Regular Sexual Stimulation…
- Expanding Your Views of Sexual Pleasure…
- Vaginal Dilators…
- Pelvic Floor Exercises…
- Vaginal Estrogen Therapy
- An effective and safe treatment, low-dose local estrogen is applied directly to the vagina…
- Government-approved low-dose vaginal estrogen products are available by prescription as vaginal creams…
- Standard doses of estrogen therapy provided to treat hot flashes also treat vaginal dryness…
- Other Prescription Therapies
- Ospemifene is an oral tablet taken daily for the treatment of painful intercourse caused by vaginal atrophy…
- Dehydroepiandrosterone (DHEA) is a hormone-containing insert placed into the vagina nightly for…”.
Health Topics A-Z
Where may I find Health Topics related to Meno Martha, Vaginal Laser Rejuvenation?
In Health Topics A-Z you may find:
- Genitourinary Syndrome of Menopause
- Hormone Therapy and Vaginal Dryness
- Hormone Therapy and Vaginal Estrogen
- Menopause Bladder and Bowel Control Problems
- Sexual Health and Menopause
- Sexual Health and Painful Intercourse
- Vaginal and Vulval Treatment Options
- Vaginal Atrophy
- Vaginal Dryness
- Women’s Health
Where may I find Links related to Meno Martha, Vaginal Laser Rejuvenation?
Your Country may have Links similar to: